Neuralink competitor Synchron buys equity stake in manufacturer
Philip O’Keefe, one of Synchron’s patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. Source: Synchron Neurotech startup Synchron is…
Philip O’Keefe, one of Synchron’s patients in the SWITCH clinical trial, was the first person in the world to tweet using a BCI device. Source: Synchron Neurotech startup Synchron is…